Paclitaxel promotes a caspase 8-mediated apoptosis through death effector domain association with microtubules

Area of Science:

• Oncology
• Cell Biology
• Biochemistry

Background:

• Microtubule-targeting drugs are key cancer chemotherapeutics, primarily acting by inducing cell-cycle arrest.
• These drugs can also trigger programmed cell death (apoptosis) through various mechanisms.
• Paclitaxel, a microtubule-stabilizing agent, induces apoptosis dependent on caspases, but its precise role remains incompletely understood.

Purpose of the Study:

• To investigate the role of caspase 8 in paclitaxel-induced apoptosis.
• To elucidate the molecular mechanisms linking caspase 8, microtubules, and paclitaxel sensitivity.

Main Methods:

• Genetic approaches were employed to compare paclitaxel sensitivity in caspase 8-expressing versus caspase 8-deficient cells.
• Immunoprecipitation and microscopy were used to assess the interaction between caspase 8 and microtubules.
• Site-directed mutagenesis was performed to identify key residues involved in microtubule binding.

Main Results:

• Cells expressing caspase 8 were significantly more sensitive to paclitaxel than those lacking it.
• Caspase 8 was found to associate with microtubules, and this association intensified upon paclitaxel treatment.
• The death effector domains (DEDs) of caspase 8 mediated microtubule interaction, while the full caspase 8 protein was necessary for apoptosis.
• A specific lysine residue (K156) in the DED-b region of caspase 8 was identified as critical for both microtubule association and paclitaxel sensitivity.

Conclusions:

• Caspase 8 plays a critical role in paclitaxel-mediated apoptosis through a novel pathway.
• The interaction between caspase 8 and microtubules, regulated by specific domains and residues, is essential for paclitaxel's cytotoxic effects.
• This study uncovers an unexpected mechanism of apoptosis induction by a widely used chemotherapeutic agent.